Clinical Trial Update: A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating aminolevulinic acid to enhance visualization and surgical removal of brain tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Glioblastoma
• Glioma

Drugs mentioned

• Aminolevulinic acid (5-aminolevulinic acid)

Snippet

Sponsor: MultiCare Health System Research Institute | Conditions: Malignant Glioma, Glioma | Phase 2 | Status: TERMINATED